Navigation Links
InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
Date:9/4/2007

- Phase 1b trial expected to begin in September -

BRISBANE, Calif., Sept. 4 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that the amended Clinical Trial Authorization (CTA) related to the Phase 1b clinical trial of ITMN-191 (Roche-R7227) has been approved by the appropriate European regulatory authorities. InterMune also has received approval from the Ethics Committee of the institutions that will conduct the Phase 1b study. ITMN-191 is an orally available hepatitis C virus (HCV) protease inhibitor in development by InterMune and its partner, Roche.

InterMune expects that the Phase 1b multiple ascending dose (MAD) study will begin this month and expects to announce initial top-line viral kinetic and safety results from the first three dose cohorts of the MAD study in the first quarter of 2008.

Dan Welch, President and Chief Executive Officer of InterMune, said, "InterMune and Roche are pleased to announce that we have successfully secured the required regulatory approvals that enable us to initiate our very important Phase 1b multiple ascending dose study. By amending the Phase 1b protocol, we believe we have enhanced our ability to deliver the most robust Phase 1b results possible which we expect will place us in a stronger position to begin our Phase 2 trials."

In early May, InterMune announced that it would amend the CTA to take into consideration new information on competitive protease inhibitors, in-vitro and preclinical data on ITMN-191 and pharmacokinetic observations from a Phase 1a study that was completed in May of 2007. In that study, a higher than anticipated exposure of ITMN-191 in plasma was observed in subjects dosed with food, suggesting tha
'/>"/>

SOURCE InterMune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive Disease Week Meeting
2. InterMune Presents Research on ITMN-191 in Hepatitis C at EASL Annual Meeting
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 Endo International plc (NASDAQ: ... revenues of $719 million, an increase of 1 percent ... Endo reported net income of $21 million in the ... million in the second quarter of 2013.  As detailed ... for the three months ended June 30, 2014 increased by ...
(Date:7/31/2014)... , 2014 Second Quarter Total Revenue $2.0 billion; an ... growth was 4% for same store sales and 8% pro ... 12% , 2014 Second Quarter GAAP EPS $0.37; Cash ... Quarter GAAP Operating Cash Flow $376 million; Adjusted Operating Cash ... Quarter , Launched 17 new products in the U.S. year-to-date ...
(Date:7/31/2014)... -- Today,s Consumer Reports story on prescription and non-prescription ... consumers of the importance of taking medicines safely ... the Acetaminophen Awareness Coalition,s (AAC) Know ... in 2010, the Coalition is a group of ... to educating consumers on safe acetaminophen use to ...
Breaking Medicine Technology:Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5
... 2011 Ventana Medical Systems, Inc . (Ventana), ... first-of-its-kind integration of the VIRTUOSO digital pathology software and ... integration to the anatomic pathology lab. The ... track the progress of a slide from preparation to ...
... 27, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: ... manufacturer and marketer of orthopedic implants in China, today announced ... Bank of America Merrill Lynch New China Conference to be ... JW Marriot Hotel in Beijing, China.  Management is scheduled to ...
Cached Medicine Technology:Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration 2Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration 3China Kanghui Holdings Announces Participation in Upcoming Investor Conferences 2
(Date:7/31/2014)... ProtonPACS, a division of Radsource, has ... Rural Health Association (NRHA), company officials announced today. The ... needs of rural health providers nationwide. , “We are ... said Dr. Mark Awh, President of Radsource. “While we ... we are also looking forward to learning from all ...
(Date:7/31/2014)... Boston, MA (PRWEB) July 31, 2014 Many ... fight for the weak, to correct injustices, and preserve the ... - action that can be lauded as crusading and exemplary ... the lawyer takes on corruption whose seed might be planted ... a fury and the ultimate punishment for an attorney - ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Computer Resources ... firm based in New York City, has been awarded ... the midtown Manhattan headquarters of a large global bank. ... investment banking. , Chico Ramnarayan, Chief Executive Officer of ... is an opportunity for us to further develop what ...
(Date:7/31/2014)... Loffler Companies, the leading business technology and ... Microsoft as a Microsoft Community Connections Partner of the ... 14, 2014. , The Microsoft U.S. SMB Champions ... cloud-based IT services and solutions to small and midsized ... SMB Champions Club member, Loffler has established a proven ...
(Date:7/31/2014)... 31, 2014 According to new ... Wheat, Mycoprotein), by Type (Tofu, Tofu-Based Product, Tempeh, ... - Global Trends & Forecasts to 2019", defines ... an analysis and forecasting of the market value ... The report also identifies the driving and restraining ...
Breaking Medicine News(10 mins):Health News:ProtonPACS Announces Pipeline Partnership with the National Rural Health Association. 2Health News:Supreme Court Press Petition of the Month for July 2014: Shutting Down Inconvenient Lawyers By Disbarment or Suspension 2Health News:Supreme Court Press Petition of the Month for July 2014: Shutting Down Inconvenient Lawyers By Disbarment or Suspension 3Health News:Global Bank Awards CRA with Network Infrastructure Contract 2Health News:Loffler Companies Named Microsoft Community Connections Partner of the Year Award Winner 2Health News:Loffler Companies Named Microsoft Community Connections Partner of the Year Award Winner 3Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 2Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 3
... by researchers at Wake Forest University Baptist Medical Center is ... weight loss in older adults leads to increased risk of ... intentionally exercised and/or modified their diets to lose weight were ... as their peers who did not work toward weight loss, ...
... give into your child,s meltdowns, expert says , SUNDAY, April ... have a hard time figuring out what to do when ... that kids often have their meltdowns in public places -- ... a Kansas State University child development expert, has compiled tips ...
... or more a week often quit their own jobs, researchers say ... more than 60 hours a week, watch out: His commitment ... , A new study finds that women with husbands who work ... expected to pick up the slack at home in regard to ...
... The law firm of Dussault ... $90,000.00 , ... 2, 2010 -- The law firm of Dussault and Zatir settled out of court a claim ... 92-year-old woman, while walking in her yard, was knocked to the ground by a neighbor’s dog. ...
... ... ... Passover and Easter, a New Jersey physician ventured into the bush country of Haiti. , ... N.J. resident, left at 4 a.m. on Friday, April 2, for a week-long medical mission ...
... tie-in to tremors and other motor problems , ... how a mutation in a gene called LRRK2 may ... , In experiments using genetically engineered mice, the Mount ... dopamine transmission and controls motor performance. Dopamine is a ...
Cached Medicine News:Health News:Belief that intentional weight loss is harmful to seniors is unfounded 2Health News:Belief that intentional weight loss is harmful to seniors is unfounded 3Health News:Dealing With Those All-Too-Public Tantrums 2Health News:Working Wives Still Expected to Do It All, Study Finds 2Health News:NJ Medical Director Travels To Haiti's Bush Country 2Health News:NJ Medical Director Travels To Haiti's Bush Country 3
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
... This remarkable anti-reflux valve is ... housing which prevents the valve ... when in sitting or reclining ... self-cleaning and interference free ensuring ...
... AggRAM, for platelet aggregation and ristocetin ... with the power of Windows-based software ... to two AggRAM modules can be ... computer so you can configure your ...
The Multiple Perfusion set provides simultaneous perfusion of the aortic root and up to three or more vein grafts. The set features an inlet port with female luer and clamp attached to an adapter whi...
Medicine Products: